Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
暂无分享,去创建一个
L. Weinberger | A. Perelson | J. Mittler | D. Ho | Xia Jin | Daniel E. Bauer | S. Tuttleton | S. Lewin | A. Gettie | J. Blanchard | C. Irwin | J. Safrit | L. Kostrikis | Linqi Zhang | Sarah Tuttleton
[1] G. Ada,et al. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus , 1978, Nature.
[2] J. H. Pope,et al. Long-term T-cell-mediated immunity to Epstein-Barr virus. , 1981, Cancer research.
[3] A. McMichael,et al. Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.
[4] H Stein,et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.
[5] P. Neuhaus,et al. THE INFLUENCE OF OKT8F TREATMENT ON ALLOGRAFT SURVIVAL IN RHESUS MONKEYS , 1986, Transplantation.
[6] J. Levy,et al. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.
[7] M. Jonker,et al. Experimental allergic encephalomyelitis in rhesus monkeys: II. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. , 1987, Clinical and experimental immunology.
[8] J. Sissons,et al. Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity , 1988, European journal of immunology.
[9] J. Sissons,et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.
[10] R. Desrosiers,et al. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.
[11] X. Jin,et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.
[12] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[13] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[14] A. McMichael,et al. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques , 1995, Nature Genetics.
[15] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[16] J. Levy,et al. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Whittle,et al. HIV‐2-specific cytotoxic T‐lymphocyte activity is inversely related to proviral load , 1995, AIDS.
[18] S. Arya,et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.
[19] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.
[20] H. Petry,et al. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. , 1995, Virology.
[21] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[22] E. Clark,et al. Formation of simian immunodeficiency virus long terminal repeat circles in resting T cells requires both T cell receptor- and IL-2-dependent activation , 1995, The Journal of experimental medicine.
[23] C. Rinaldo,et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.
[24] Sanjay Tyagi,et al. Molecular Beacons: Probes that Fluoresce upon Hybridization , 1996, Nature Biotechnology.
[25] K. Harada,et al. Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.
[26] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[27] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[28] R. Stebbings,et al. Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. , 1997, The Journal of general virology.
[29] T. Greenough,et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. , 1997, The Journal of infectious diseases.
[30] R P Johnson,et al. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.
[31] R. Desrosiers,et al. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus , 1997, Journal of virology.
[32] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[33] M. Kersten,et al. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. , 1997, The Journal of clinical investigation.
[34] J. Smith,et al. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. , 1997, Virology.
[35] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Cobbold,et al. Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. , 1998, AIDS research and human retroviruses.
[37] R. Means,et al. Inhibition of Simian Immunodeficiency Virus (SIV) Replication by CD8+ T Lymphocytes from Macaques Immunized with Live Attenuated SIV , 1998, Journal of Virology.
[38] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[39] A. Perelson,et al. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. , 1998, Mathematical biosciences.
[40] D. Ho,et al. Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 1998, Journal of Virology.
[41] J. Lifson,et al. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. , 1998, AIDS research and human retroviruses.
[42] H. Clifford Lane,et al. Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques , 1998, Journal of Virology.
[43] Fred Russell Kramer,et al. Spectral Genotyping of Human Alleles , 1998, Science.